Congenital myasthenic syndrome by mutation of the ColQ gene: Phenotypic and evolutionary profile of three Algerian families

Rev Neurol (Paris). 2023 Jun;179(6):570-575. doi: 10.1016/j.neurol.2022.09.008. Epub 2023 Feb 8.

Abstract

Background: Congenital myasthenic syndromes (CMS) are rare genetic neuromuscular disorders. The COLQ gene encoding the collagenous subunit of the acetyl cholinesterase enzyme tail is implicated in a synaptic form of CMS (also called type 5, according to the new gene table 2020 classification).

Objective: To study the clinical phenotype of three families with COLQ gene mutations.

Methods: We report a series of three consanguineous families, with seven affected patients, carrying three different mutations of the COLQ gene, one of which has never been reported in the literature before.

Results: We studied their clinical and paraclinical phenotypes, and try to compare the three families as well as compare them with other series carrying COLQ gene mutations reported in the literature.

Conclusion: COLQ gene mutations have phenotypic particularities that must be recognized to propose appropriate genetic study.

Keywords: COLQ; Congenital; Myasthenia; Phenotypes; Synaptic.

MeSH terms

  • Acetylcholinesterase / genetics
  • Humans
  • Muscle Proteins / genetics
  • Mutation
  • Myasthenic Syndromes, Congenital* / diagnosis
  • Myasthenic Syndromes, Congenital* / genetics
  • Phenotype

Substances

  • Muscle Proteins
  • Acetylcholinesterase